Boston Globe coverage of the progress of the Massachusetts health cost containment and quality bill, which was debated in the House yesterday, runneth over – The gist The letters Lisa Kaplan Howe, Health Care for All Brian Hurley, American Medical Studen

Today's blog comes to us courtesy of RxP data-master Ian Reynolds. Yesterday, just as PhRMA was announcing revisions to strengthen its voluntary Code on Interactions with Health Care Professionals, the Vermont attorney general was putting out a report o

PhRMA announces changes to marketing code The main trade association of the drug industry, Pharmaceutical Researchers and Manufacturers of America, announced today it is revising its voluntary code ‘Interactions with Healthcare Professionals’ to ban small

Our Fellow coalitioneers over at Health Care for All have a good post on the Massachusetts pharma gift ban as we await word on whether House lawmakers will include the section in its recommended version of the health care cost containment bill being final

This week, Pfizer announced that it will stop funding physician continuing medical education through medical education and communication companies (MECCs), effective immediately. According to the company’s press release, the move is meant to curb conflict

We've written a lot on the past few months about the national class action lawsuit against Abbott Laboratories, targetting Abbott's December 2003 400% price increase on its HIV/AIDS drug Norvir. The case has survived Abbott's numerous attempts to have it

PAL extends an enthusiastic welcome to International Union of Operating Engineers (IUOE) Local 98 to our Coalition. . Local 98 represents approximately 1,300 members, including heavy equipment operators and mechanics, equipment house employees and munici

We’re late out of the gate on this one, but the numbers still bear mentioning – a report from the Center for Public Integrity out last month showed that the pharmaceutical industry’s been getting its money’s worth on K Street. Good news for the industry,

The fourth national Integrity in Science conference is coming up on July 11th  in Washington D.C. At “Rejuvenating Public Sector Science,” join lead thinkers, policymakers, and regulators as they discuss priorities for the national agenda and ways to curb